Developing imaging agents for Alzheimer's and related diseases
Medicinal Chemistry and Radiochemistry Core
This study is working on new imaging tools that can help doctors see specific proteins linked to Alzheimer's and other brain diseases, which could lead to better diagnoses and treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10940632 on NIH RePORTER |
What this research studies
This research focuses on creating specialized imaging agents, known as radiotracers, that can help visualize specific proteins associated with Alzheimer's disease and other neurodegenerative conditions. The project involves collaboration among three major institutions and utilizes advanced techniques in chemical biology, structural biology, and computational modeling to optimize these imaging agents. Patients may benefit from improved diagnostic tools that can lead to better-targeted treatments for conditions like Alzheimer's, Parkinson's disease, and related disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease, Parkinson's disease, or other related neurodegenerative disorders.
Not a fit: Patients with non-neurodegenerative conditions or those without a diagnosis of Alzheimer's or related diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and earlier diagnoses of Alzheimer's and related neurodegenerative diseases.
How similar studies have performed: Previous research has shown promise in developing imaging agents for neurodegenerative diseases, indicating that this approach has potential for success.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Mach, Robert H — University of Pennsylvania
- Study coordinator: Mach, Robert H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.